SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.210-14.2%Nov 4 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Goodman who wrote (354)4/29/1998 8:09:00 AM
From: Don W Stone  Read Replies (1) of 507
 
Goodman; Don't get to carried away with those "technicals".
On this round when NVX returns to its old high it is going to keep right on going.
I have a lot of company that think NVX will more than triple from this level just on the added drive that the short position will provide.

As one individual,who is indeed a very mature sophisticated investor/broker says. " ORG is a good road map for NVX". ORG on just an Advisory Committee meeting report went from low 20's to mid 40's in a matter of a couple of months.

NVX will get the FDA approval sometime soon. T
hey will surprise the market with their initial influx of orders,after all the potential buyers have been pent up waiting.
The stock will take off big time, IMO

NVX today is a "screaming buy".
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext